13 Healthcare M&A Deals Transacted in Q2 2022

Commentary by: Eric Murphy, Managing Director, Global Healthcare Services

Kauffman Hall reported in its “Healthcare M&A Activity Report: Q2 2022” that the second quarter of 2022 had 13 announced M&A transactions including, most notably, the merger of Advocate Aurora Health and Atrium Health. The smaller party, Atrium Health, had a total transaction revenue of $12.9 billion, qualifying the deal as a “mega” transaction, which is characterized by Kauffman Hall as a transaction where the smaller party or seller has annual revenues of more than $1 billion. The other mega transaction announced in Q2 2022 was Trinity Health’s acquisition of MercyOne from CommonSpirit Health. The size of these transactions attributed to the doubling of the last year’s average smaller party/seller size for the quarter.

As we have reported over the past 12 to 24 months, the trend will likely continue towards fewer transactions of a greater size. Last quarter was an outlier where no mega transactions were announced, and the average smaller party/seller size was $246 million.


Source: Kaufman, Hall & Associates, LLC

All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our

Sign Up for Our Newsletter